Patents Assigned to Genia Technologies, Inc.
  • Patent number: 11361843
    Abstract: A system includes a plurality of nanopore cells. Data corresponding to nanopore states of the plurality of nanopore cells is received. The data is analyzed to determine a compressed output size of the data given at least one compression technique. It is determined whether the compressed output size exceeds a data budget. In the event it is determined that the compressed output size exceeds the data budget, the data is modified. The modified data is outputted.
    Type: Grant
    Filed: August 30, 2018
    Date of Patent: June 14, 2022
    Assignee: Genia Technologies, Inc.
    Inventors: Santiago Fernandez-Gomez, Hui Tian, J. William Maney, Jayalakshmi Rajaraman
  • Publication number: 20200216887
    Abstract: A method is provided for preparing nanopore sequencing complexes in membranes for sequencing of polymers, e.g., polynucleotides and polypeptides. The nanopore sequencing complex is formed by the sequential linking of an enzyme to a nanopore that is inserted in a membrane, and of a polymer to the enzyme. Alternatively, the nanopore sequencing complex is formed by linking a preformed enzyme-polymer complex to a nanopore that is inserted in a membrane. The enzyme polymer complex is interchangeable.
    Type: Application
    Filed: January 20, 2017
    Publication date: July 9, 2020
    Applicant: Genia Technologies, Inc.
    Inventors: Timothy Kellogg Craig, Christos Tzitzilonis, Alexander H. Yang, Liv E. Jensen, Marshall Porter, Charlotte Yang, Corissa Harris, Matt Dipetro
  • Publication number: 20190367977
    Abstract: Described herein are methods and devices for capturing and determining the identity of molecules using nanopores. The molecules can be counted, sorted and/or binned rapidly in a parallel manner using a large number of nanopores (e.g., 132,000 nanopores reading 180 million molecules in 1 hour). This fast capture and reading of a molecule can be used to capture probe molecules or other molecules that have been generated to represent an original, hard to detect molecule or portions of an original molecule. Precise counting of sample molecules or surrogates for sample molecules can occur. The methods and devices described herein can, among other things, replace flow cytometers and other counting instruments (e.g., while providing increased precision and throughput relative to a flow cytometer).
    Type: Application
    Filed: August 20, 2019
    Publication date: December 5, 2019
    Applicant: GENIA TECHNOLOGIES, INC.
    Inventor: Randall Davis
  • Publication number: 20190292591
    Abstract: Systems and methods of polynucleotide sequencing are provided. Systems and methods optimize control, speed, movement, and/or translocation of a sample (e.g., a polynucleotide) within, through, or at least partially through a nanopore or a type of protein or mutant protein in order to accumulate sufficient time and current blocking information to identify contiguous nucleotides or plurality of nucleotides in a single-stranded area of a polynucleotide.
    Type: Application
    Filed: March 12, 2019
    Publication date: September 26, 2019
    Applicants: GENIA TECHNOLOGIES, INC., LIFE TECHNOLOGIES CORPORATION
    Inventors: Timothy GEISER, Randall DAVIS, Roger CHEN
  • Patent number: 10421995
    Abstract: Described herein are methods and devices for capturing and determining the identity of molecules using nanopores. The molecules can be counted, sorted and/or binned rapidly in a parallel manner using a large number of nanopores (e.g., 132,000 nanopores reading 180 million molecules in 1 hour). This fast capture and reading of a molecule can be used to capture probe molecules or other molecules that have been generated to represent an original, hard to detect molecule or portions of an original molecule. Precise counting of sample molecules or surrogates for sample molecules can occur. The methods and devices described herein can, among other things, replace flow cytometers and other counting instruments (e.g., while providing increased precision and throughput relative to a flow cytometer).
    Type: Grant
    Filed: October 23, 2014
    Date of Patent: September 24, 2019
    Assignee: GENIA TECHNOLOGIES, INC.
    Inventor: Randall Davis
  • Publication number: 20190276887
    Abstract: This disclosure provides systems and methods for attaching nanopore-detectable tags to nucleotides. The disclosure also provides methods for sequencing nucleic acids using the disclosed tagged nucleotides.
    Type: Application
    Filed: March 25, 2019
    Publication date: September 12, 2019
    Applicants: The Trustees of Columbia University in the City of New York, Genia Technologies, Inc.
    Inventors: Carl W. FULLER, Shiv KUMAR, Jingyue JU, Randall DAVIS, Roger CHEN
  • Patent number: 10400278
    Abstract: The present invention relates to a method of using nanopores to obtain sequence information of sample DNAs in ss test DNAs. The method comprises using speed bumps to stall the ss test DNAs in the nanopores at random positions of the ss test DNAs to obtain sequence information of each and every nucleotides of the sample DNAs, and to construct the whole sequences of the sample DNAs. The present invention also relates to identification and/or isolation of test DNAs having desired sequence(s) using nanopore detectors facilitated by speed bump.
    Type: Grant
    Filed: February 16, 2017
    Date of Patent: September 3, 2019
    Assignee: Genia Technologies, Inc.
    Inventors: Randall W Davis, Roger J. A. Chen
  • Publication number: 20190264275
    Abstract: The present invention relates to a method of using nanopores to obtain sequence information of sample DNAs in ss test DNAs. The method comprises using speed bumps to stall the ss test DNAs in the nanopores at random positions of the ss test DNAs to obtain sequence information of each and every nucleotides of the sample DNAs, and to construct the whole sequences of the sample DNAs. The present invention also relates to identification and/or isolation of test DNAs having desired sequence(s) using nanopore detectors facilitated by speed bump.
    Type: Application
    Filed: April 17, 2019
    Publication date: August 29, 2019
    Applicant: GENIA TECHNOLOGIES, INC.
    Inventors: Randall W. DAVIS, Roger J.A. CHEN
  • Publication number: 20190249244
    Abstract: The present disclosure provides biochips and methods for making biochips. A biochip can comprise a nanopore in a membrane (e.g., lipid bilayer) adjacent or in proximity to an electrode. Methods are described for forming the membrane and insert-ing the nanopore into the membrane. The biochips and methods can be used for nucleic acid (e.g., DNA) sequencing. The present disclosure also describes methods for detecting, sorting, and binning molecules (e.g., proteins) using biochips.
    Type: Application
    Filed: April 26, 2019
    Publication date: August 15, 2019
    Applicant: GENIA TECHNOLOGIES, INC.
    Inventors: Randall DAVIS, Roger CHEN
  • Patent number: 10371692
    Abstract: A method of forming a nanopore in a lipid bilayer is disclosed. A nanopore forming solution is deposited over a lipid bilayer. The nanopore forming solution has a concentration level and a corresponding activity level of pore molecules such that nanopores are substantially not formed un-stimulated in the lipid bilayer. Formation of a nanopore in the lipid bilayer is initiated by applying an agitation stimulus level to the lipid bilayer. In some embodiments, the concentration level and the corresponding activity level of pore molecules are at levels such that less than 30 percent of a plurality of available lipid bilayers have nanopores formed un-stimulated therein.
    Type: Grant
    Filed: April 14, 2017
    Date of Patent: August 6, 2019
    Assignee: GENIA TECHNOLOGIES, INC.
    Inventors: Roger J. A. Chen, Randy Davis
  • Publication number: 20190225656
    Abstract: Described herein are variants of alpha-hemolysin having at least one mutation selected from T12R, T12K, N17R, N17K or combinations of T12 and N17 mutations. The variants in some embodiments may further comprise H144A. The ?-hemolysin variants have a decreased time to thread.
    Type: Application
    Filed: April 4, 2019
    Publication date: July 25, 2019
    Applicant: Genia Technologies, Inc.
    Inventors: Michael Dorwart, Daniel Korenblum
  • Patent number: 10343350
    Abstract: Techniques for forming a nanopore in a lipid bilayer are described herein. In one example, an agitation stimulus level such as an electrical agitation stimulus is applied to a lipid bilayer wherein the agitation stimulus level tends to facilitate the formation of nanopores in the lipid bilayer. In some embodiments, a change in an electrical property of the lipid bilayer resulting from the formation of the nanopore in the lipid bilayer is detected, and a nanopore has formed in the lipid bilayer is determined based on the detected change in the lipid bilayer electrical property.
    Type: Grant
    Filed: January 20, 2017
    Date of Patent: July 9, 2019
    Assignee: Genia Technologies, Inc.
    Inventors: Roger J. A. Chen, Randy Davis
  • Patent number: 10345290
    Abstract: A nanopore sequencing device is disclosed. The nanopore sequencing device includes a working electrode. It further includes a dielectric layer, wherein a portion of the dielectric layer is disposed horizontally adjacent to the working electrode and a portion of the dielectric layer is disposed above and covering a portion of the working electrode, and wherein the dielectric layer forms a well having an opening above an uncovered portion of the working electrode. A base surface area of the working electrode is greater than a base surface area of the opening above the uncovered portion of the working electrode.
    Type: Grant
    Filed: June 28, 2018
    Date of Patent: July 9, 2019
    Assignee: Genia Technologies, Inc.
    Inventors: Jennifer Hovis, Hui Tian, Roger J. A. Chen
  • Patent number: 10330633
    Abstract: A system for communicating information from an array of sensors is disclosed. The system comprises a sensor array that includes a plurality of sensors, wherein each sensor senses a physical property of a material that is in communication with the sensor. The system further comprises signal processing circuitry associated with each sensor that integrates the output of the sensor over time and compares the integrated output to a threshold. The system further comprises a communication network coupled to the signal processing circuitry that outputs information indicating that the integrated output corresponding to a given sensor has reached the threshold.
    Type: Grant
    Filed: December 15, 2016
    Date of Patent: June 25, 2019
    Assignee: Genia Technologies, Inc.
    Inventor: Roger J. A. Chen
  • Publication number: 20190185927
    Abstract: This disclosure provides a biochip comprising a plurality of wells. The biochip includes a membrane that is disposed in or adjacent to an individual well of the plurality of wells. The membrane comprises a nanopore, and the individual well comprises an electrode that detects a signal upon ionic flow through the pore in response to a species passing through or adjacent to the nanopore. The electrode can be a non-sacrificial electrode. A lipid bilayer can be formed over the plurality of wells using a bubble.
    Type: Application
    Filed: February 11, 2019
    Publication date: June 20, 2019
    Applicant: Genia Technologies, Inc.
    Inventors: Randall W. DAVIS, Edward Shian LIU, Eric Takeshi HARADA, Anne AGUIRRE, Andrew TRANS, James POLLARD, Cynthia CECH
  • Patent number: 10316360
    Abstract: Provided is a method for detecting a target molecule. The method includes providing a chip, the chip including a nanopore in a membrane that is disposed adjacent to or in proximity to a sensing electrode. A nucleic acid molecule is then directed through the nanopore, the nucleic acid molecule being associated with a reporter molecule. The nucleic acid molecule also includes an address region and a probe region, the reporter molecule being associated with the nucleic acid molecule at the probe region. The reporter molecule is also coupled to a target molecule. While the nucleic acid molecule is directed through the nanopore, the address region can be sequenced to determine a nucleic acid sequence of the address region. The target molecule can then be identified, with the aid of a computer processor, based upon the nucleic acid sequence of the address region.
    Type: Grant
    Filed: November 10, 2017
    Date of Patent: June 11, 2019
    Assignee: GENIA TECHNOLOGIES, INC.
    Inventors: Randall Davis, Roger Chen
  • Patent number: 10308918
    Abstract: Described herein are variant pol6 polymerase having at least having at least two substitutions, wherein at least one of the substitutions is at position S366 of SEQ ID NO: 2. The disclosed polymerases may be coupled to alpha-hemolysin nanopores, and may be used in nanopore-based sequencing apparatuses.
    Type: Grant
    Filed: February 1, 2016
    Date of Patent: June 4, 2019
    Assignees: Roche Molecular Systems, Inc., Genia Technologies, Inc.
    Inventors: Aruna Ayer, Arkadiusz Bibillo, Cleoma Renetta Arnold, Charles Wayan Schwab, Eileen Thai, Ilya Lederman, Colin Alexander McGaw, Tyler O'Brien Shultz, Barbara Eckert, Shawn Suko, Mara Boenitz-Dulat, Bigna Woersdoerfer, David Daniel Wunderlich
  • Patent number: 10301361
    Abstract: Described herein are variants of alpha-hemolysin having at least one mutation selected from T12R, T12K, N17R, N17K or combinations of T12 and N17 mutations. The variants in some embodiments may further comprise H144A. The ?-hemolysin variants have a decreased time to thread.
    Type: Grant
    Filed: October 28, 2015
    Date of Patent: May 28, 2019
    Assignee: GENIA TECHNOLOGIES, INC.
    Inventors: Michael Dorwart, Daniel Korenblum
  • Patent number: 10273536
    Abstract: A biochip for molecular detection and sensing is disclosed. The biochip includes a substrate. The biochip includes a plurality of discrete sites formed on the substrate having a density of greater than five hundred wells per square millimeter. Each discrete site includes sidewalls disposed on the substrate to form a well. Each discrete site includes an electrode disposed at the bottom of the well. In some embodiments, the wells are formed such that cross-talk between the wells is reduced. In some embodiments, the electrodes disposed at the bottom of the wells are organized into groups of electrodes, wherein each group of electrodes shares a common counter electrode. In some embodiments, the electrode disposed at the bottom of the well has a dedicated counter electrode. In some embodiments, surfaces of the sidewalls are silanized such that the surfaces facilitate the forming of a membrane in or adjacent to the well.
    Type: Grant
    Filed: March 10, 2016
    Date of Patent: April 30, 2019
    Assignees: GENIA TECHNOLOGIES, INC., ROCHE MOLECULAR SYSTEMS, INC.
    Inventors: Randall W. Davis, Edward Shian Liu, Eric Takeshi Harada, Anne Aguirre, Andrew Trans, James Pollard, Cynthia Cech, Hui Tian, Robert Yuan, John Foster, Roger Chen
  • Publication number: 20190119745
    Abstract: Described herein are engineered alpha-hemolysin subunits having mutated oligomerization domains for assembling into heptameric nanopores in lipid bilayers.
    Type: Application
    Filed: January 3, 2019
    Publication date: April 25, 2019
    Applicant: GENIA TECHNOLOGIES, INC.
    Inventors: Timothy Kellogg CRAIG, Cynthia Ann CECH, Michael DORWART, Liv Elisabeth JENSEN, Marshall Winston PORTER, Christos TZITZILONIS, Alexander Hyun-min YANG